Skip to main content

Table 5 Characteristics of patients following initial TACE with AFP ≥ 200 ng/ml vs. < 200 ng/ml

From: Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation

Repeat serum AFP subgroup n = 177      
Variable n AFP < 200 ng/ml n AFP ≥ 200 ng/ml P value
Pre-TACE, % (n)
 Caucasian 147 83.7% (123) 30 63.3% (19) 0.011
 HCV 147 41.5% (61) 30 70% (21) 0.004
 HBV 147 17.7% (26) 30 33.3% (10) 0.05
 T2DM 147 34.7% (51) 30 16.7% (5) 0.05
 BCLC stage C 147 2% (3) 30 13.3% (4) 0.017
 Macrovascular invasion 147 1.4% (2) 30 10% (3) 0.035
 tumour size, (cm), mean (SD) 147 3.84 (2.55) 30 5.64 (3.89) 0.002
Post initial TACE, median (IQR)
 Neutrophils, x10^9/L 91 2.9 [2.3-3.72] 23 4.2 [2.9-5.1] 0.001
 ALT, U/L 146 38.5 [24-72] 29 65 [34-100] 0.03
 Na, mmol/L 145 138 [136-140] 28 137 [135-139] 0.048